Shijun J Zheng Selected Research

Virus Diseases (Viral Diseases)

1/2023	Reduced NR2F2 Expression in the Host Response to Infectious Bursal Disease Virus Infection Suppressed Viral Replication by Enhancing Type I Interferon Expression by Targeting SOCS5.
1/2022	GATA3 Inhibits Viral Infection by Promoting MicroRNA-155 Expression.
1/2020	Corrigendum: gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK.
11/2019	The Roles of MicroRNAs (miRNAs) in Avian Response to Viral Infection and Pathogenesis of Avian Immunosuppressive Diseases.
1/2018	MicroRNA gga-miR-130b Suppresses Infectious Bursal Disease Virus Replication via Targeting of the Viral Genome and Cellular Suppressors of Cytokine Signaling 5.
1/2018	gga-miR-155 Enhances Type I Interferon Expression and Suppresses Infectious Burse Disease Virus Replication via Targeting SOCS1 and TANK.
1/2018	gga-miR-454 suppresses infectious bursal disease virus (IBDV) replication via directly targeting IBDV genomic segment B and cellular Suppressors of Cytokine Signaling 6 (SOCS6).
9/2013	Engagement of soluble resistance-related calcium binding protein (sorcin) with foot-and-mouth disease virus (FMDV) VP1 inhibits type I interferon response in cells.
1/2013	Critical roles of glucocorticoid-induced leucine zipper in infectious bursal disease virus (IBDV)-induced suppression of type I Interferon expression and enhancement of IBDV growth in host cells via interaction with VP4.
1/2013	Engagement of new castle disease virus (NDV) matrix (M) protein with charged multivesicular body protein (CHMP) 4 facilitates viral replication.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shijun J Zheng Research Topics

Disease

24	Infections 01/2023 - 02/2012
10	Virus Diseases (Viral Diseases) 01/2023 - 01/2013
3	Vesicular Stomatitis 01/2017 - 09/2013
2	Inflammation (Inflammations) 02/2024 - 01/2017
2	Communicable Diseases (Infectious Diseases) 07/2022 - 01/2022
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 07/2022 - 01/2022
2	Necrosis 01/2022 - 01/2011
2	Neoplasms (Cancer) 02/2012 - 06/2011
1	Bites and Stings (Sting) 01/2023
1	Coronavirus Infections 07/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Lymphoma (Lymphomas) 01/2020
1	Carcinogenesis 11/2019
1	Hepatocellular Carcinoma (Hepatoma) 01/2019
1	Infectious Arthritis (Septic Arthritis) 01/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2018
1	Malabsorption Syndromes (Malabsorption Syndrome) 01/2018
1	Mouth Neoplasms (Oral Cancer) 01/2017
1	Escherichia coli Infections 09/2008

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2011
10	MicroRNAs (MicroRNA)IBA 02/2024 - 01/2018
10	Interferon Type IIBA 01/2023 - 01/2013
6	RNA (Ribonucleic Acid)IBA 07/2022 - 01/2018
4	Antiviral Agents (Antivirals)IBA 01/2023 - 01/2020
2	CytokinesIBA 07/2022 - 09/2008
2	Pattern Recognition ReceptorsIBA 07/2022 - 01/2022
2	Pathogen-Associated Molecular Pattern MoleculesIBA 07/2022 - 01/2022
2	InflammasomesIBA 07/2022 - 01/2022
2	InterferonsIBA 07/2022 - 01/2022
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
2	VaccinesIBA 01/2022 - 01/2022
2	Indicators and Reagents (Reagents)IBA 01/2022 - 01/2022
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2013 - 09/2008
1	Neutralizing AntibodiesIBA 01/2023
1	COUP Transcription Factor IIIBA 01/2023
1	Capsid Proteins (Capsid Protein)IBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	Nucleic AcidsIBA 07/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Poly I-CIBA 01/2022
1	Double-Stranded RNA (RNA, Double Stranded)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Caspase 3 (Caspase-3)IBA 01/2022
1	IgA receptor (protein B)IBA 01/2020
1	Virulence Factors (Pathogenicity Factors)IBA 01/2020
1	Caspase InhibitorsIBA 01/2020
1	Viral ProteinsIBA 01/2020
1	pyrazolanthroneIBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Oncogene Proteins (Oncogene Protein)IBA 01/2017
1	Calcium-Binding ProteinsIBA 01/2017
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 01/2017
1	Matrix-MIBA 01/2013
1	FlagellinIBA 04/2012
1	Therapeutic UsesIBA 02/2012
1	Monoclonal AntibodiesIBA 01/2011
1	Amino Acids FDA Link 01/2011
1	Interleukin-12 (IL 12)IBA 09/2008
1	Interleukin-1 (Interleukin 1)IBA 09/2008
1	Interleukin-6 (Interleukin 6)IBA 09/2008